
About
Levostar Biotech is a biotechnology company providing gene synthesis, plasmid preparation, RNA production, LNP encapsulation, and in vivo CAR-T-related products. It serves academic, commercial, and government customers from operations in China and the United States, with global support for biopharmaceutical partners.
Services
Gene Synthesis
Gene synthesis for complex sequences including repeat sequences, high-GC content sequences, and ITR structures, with codon optimization and vector construction recommendations.
Plasmid Preparation
Plasmid DNA options from 5 µg to 100 mg, offered lyophilized or liquid, with selectable supercoiling and endotoxin levels.
IVT RNA Synthesis
In vitro transcribed RNA production as part of an integrated RNA platform spanning sequence to RNA.
mRNA Synthesis
mRNA synthesis within a fully integrated RNA production platform.
circRNA Synthesis
Custom circular RNA synthesis through the company’s proprietary IVT manufacturing platform.
saRNA Synthesis
Self-amplifying RNA synthesis for RNA payloads that encode a replicase.
sgRNA Synthesis
sgRNA synthesis for precision editing applications.
LNP Encapsulation
Lipid nanoparticle encapsulation services integrated with gene synthesis and RNA production.
8 more services
- In vivo CAR-T Platform
- mRNA-tLNP
- In-stock mRNA Products
- In-stock In Vivo CAR-T Related Products
- Catalog DNA Products
- RNA Transfection Kit
- Sample Storage Tubes and Instruments
- monoPlasmid
- Turnaround
- 3 days to 5 days
- What to send
- Sequence input in nucleotide or amino acid format
- Country/region and institution type for requests
- Nucleotide or amino acid sequences
- Up to 100,000 bp
- Customer vector or choice from Levostar vector library
Capabilities
- Assays and studies
- mRNA
- Cell therapy
- In vivo
- LNP
- Antibodies
- Lyophilization
8 more
- NGS
- Sanger sequencing
- Sequence verification
- Nanoparticle characterization
- Cell expression
- In vivo functional validation
- In vivo CAR-T characterization
- Analytical testing
- Scale and capacity
- Up to 100,000 bp
- 5 µg to 100 mg
- 200 µg package size
- 48-tube library
- Therapeutic areas
- In vivo CAR-T
- Cell and gene therapy
- RNA therapeutics
- Antibody discovery
- Gene editing
- Hematological malignancies
3 more
- Solid tumors
- Autoimmune diseases
- Infectious diseases
Modalities and species
- Modalities
- Antibody
- ADC
- mRNA
- Cell therapy
- Gene editing
- Plasmid DNA
- LNP / formulation
- Species and models
- T cells
- Jurkat
- SUP-T1
- A549
- 293T
- Human
Industries served
- Biopharmaceutical
- Academic
- Government
Details
- Quality
- 100% Sequence Accuracy · >99% Success Rate · >95% On-Time Delivery · >90% supercoiled plasmid · GMP-compliant facility (sample storage tubes and automated sample storage instruments)
- Office
- 16192 Coastal Hwy,Lewes, DE 19958
- Sites
- Lewes, United States
- Serves
- Worldwide, global, United States, China, Europe, Asia, Americas, South America
- Phone
- 619-537-9202